A detailed history of Capital Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Investment Advisors, LLC holds 188,334 shares of ABBV stock, worth $37.8 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
188,334
Previous 187,952 0.2%
Holding current value
$37.8 Million
Previous $32.2 Million 15.37%
% of portfolio
0.78%
Previous 0.74%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$163.84 - $199.33 $62,586 - $76,144
382 Added 0.2%
188,334 $37.2 Million
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $496,566 - $579,878
3,208 Added 1.74%
187,952 $32.2 Million
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $172,925 - $197,032
1,082 Added 0.59%
184,744 $33.6 Million
Q4 2023

Jan 05, 2024

BUY
$137.6 - $154.97 $77,193 - $86,938
561 Added 0.31%
183,662 $28.5 Million
Q3 2023

Oct 16, 2023

SELL
$133.59 - $154.65 $157,636 - $182,487
-1,180 Reduced 0.64%
183,101 $27.3 Million
Q2 2023

Jul 11, 2023

SELL
$132.51 - $164.9 $355,921 - $442,921
-2,686 Reduced 1.44%
184,281 $24.8 Million
Q1 2023

Apr 10, 2023

BUY
$144.61 - $166.54 $593,045 - $682,980
4,101 Added 2.24%
186,967 $29.8 Million
Q4 2022

Jan 05, 2023

BUY
$138.31 - $165.87 $423,781 - $508,225
3,064 Added 1.7%
182,866 $29.6 Million
Q3 2022

Oct 05, 2022

BUY
$134.21 - $153.93 $993,690 - $1.14 Million
7,404 Added 4.29%
179,802 $24.1 Million
Q2 2022

Jul 06, 2022

BUY
$137.62 - $174.96 $271,524 - $345,196
1,973 Added 1.16%
172,398 $26.4 Million
Q1 2022

Apr 13, 2022

SELL
$131.98 - $163.75 $44,081 - $54,692
-334 Reduced 0.2%
170,425 $27.6 Million
Q4 2021

Jan 10, 2022

BUY
$107.43 - $135.93 $524,688 - $663,882
4,884 Added 2.94%
170,759 $23.1 Million
Q3 2021

Oct 13, 2021

BUY
$106.4 - $120.78 $983,880 - $1.12 Million
9,247 Added 5.9%
165,875 $17.9 Million
Q2 2021

Jul 14, 2021

BUY
$105.21 - $117.21 $951,203 - $1.06 Million
9,041 Added 6.13%
156,628 $17.6 Million
Q1 2021

Apr 27, 2021

BUY
$102.3 - $112.62 $1.22 Million - $1.35 Million
11,963 Added 8.82%
147,587 $16 Million
Q4 2020

Jan 21, 2021

BUY
$80.49 - $108.67 $752,822 - $1.02 Million
9,353 Added 7.41%
135,624 $14.5 Million
Q3 2020

Oct 29, 2020

BUY
$85.91 - $100.83 $571,559 - $670,821
6,653 Added 5.56%
126,271 $11.1 Million
Q2 2020

Jul 20, 2020

BUY
$73.37 - $98.18 $941,483 - $1.26 Million
12,832 Added 12.02%
119,618 $11.7 Million
Q1 2020

Apr 13, 2020

SELL
$64.5 - $97.79 $131,644 - $199,589
-2,041 Reduced 1.88%
106,786 $8.14 Million
Q4 2019

Jan 21, 2020

BUY
$72.13 - $90.25 $538,738 - $674,077
7,469 Added 7.37%
108,827 $9.64 Million
Q3 2019

Oct 24, 2019

BUY
$62.98 - $75.72 $1.38 Million - $1.66 Million
21,943 Added 27.63%
101,358 $7.68 Million
Q2 2019

Jul 17, 2019

BUY
$65.7 - $83.98 $1.14 Million - $1.46 Million
17,396 Added 28.05%
79,415 $5.78 Million
Q1 2019

Apr 11, 2019

BUY
$77.14 - $90.79 $1.12 Million - $1.31 Million
14,469 Added 30.43%
62,019 $5 Million
Q4 2018

Jan 17, 2019

BUY
$77.85 - $96.01 $726,574 - $896,061
9,333 Added 24.42%
47,550 $4.38 Million
Q3 2018

Oct 15, 2018

BUY
$88.91 - $98.84 $306,206 - $340,404
3,444 Added 9.9%
38,217 $3.62 Million
Q2 2018

Jul 10, 2018

BUY
$89.78 - $106.23 $677,479 - $801,611
7,546 Added 27.72%
34,773 $3.22 Million
Q1 2018

Apr 16, 2018

BUY
$92.01 - $123.21 $78,392 - $104,974
852 Added 3.23%
27,227 $2.58 Million
Q4 2017

Jan 17, 2018

SELL
$89.56 - $98.21 $556,346 - $610,080
-6,212 Reduced 19.06%
26,375 $2.55 Million
Q3 2017

Oct 17, 2017

BUY
$69.85 - $89.22 $2.28 Million - $2.91 Million
32,587
32,587 $2.9 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Investment Advisors, LLC Portfolio

Follow Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.